Namrata Rastogi, PhD, obtained her doctorate from the Central Drug Research Institute in Lucknow, India in 2014. She further trained as a post-doctoral fellow specialising in chemo-resistant breast cancer at King George’s Medical University and became a Research Associate at Cardiff University in the UK, working on acute myeloid leukemia (AML) cell signalling. Dr Rastogi is currently a Research Fellow at Cardiff University.
Speaking on the role of transcription factors in AML
Dr Rastogi’s research focuses on the role of transcription factors on the process of hematopoiesis and initiation of AML. She has also established the role of targeting CD200 with monoclonal antibody therapy in the treatment of AML